Veradermics, a developer of an oral treatment for pattern hair loss, began trading on the New York Stock Exchange with shares ...
Veradermics is set to raise $200 million in an IPO to fund its novel extended-release oral minoxidil for pattern hair loss.
An Initial Public Offering (IPO) is when a private company offers its shares to the public for the first time, allowing investors to buy a stake and the company to raise capital for growth.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results